Insider Trading June 23, 2026 04:27 PM

Cadre Holdings CEO Warren Kanders Offloads $2.07M in Stock Amid Q1 Earnings Miss and Major FBI Contract Win

Warren B. Kanders executes dual transactions totaling 75,000 shares, while the company navigates a 34% stock decline and reports Q1 results below consensus alongside a significant Safariland government contract.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
CDRE

Cadre Holdings, Inc. (NASDAQ:CDRE) Chief Executive Officer and Chairman Warren B. Kanders recently divested a substantial portion of his equity stake in the firm, selling 75,000 shares through his affiliated entity, Kanders SAF, LLC. These transactions, valued at approximately $2.07 million, occurred as the company's stock traded near its 52-week low of $25.73, reflecting a 34% decline over the past six months. Concurrently, Cadre Holdings reported its first-quarter 2026 financial results, which fell short of market expectations for both earnings per share and revenue. Despite the recent earnings miss, the company's subsidiary, Safariland, secured a lucrative five-year, $61 million contract with the Federal Bureau of Investigation to supply ballistic panels, extending the availability of its armor systems to additional Department of Justice agencies.

Cadre Holdings CEO Warren Kanders Offloads $2.07M in Stock Amid Q1 Earnings Miss and Major FBI Contract Win
CDRE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Warren B. Kanders sold 75,000 shares through Kanders SAF, LLC for approximately $2.07 million in June 2026.
  • Cadre Holdings reported Q1 2026 earnings of $0.05 per share and $155.4 million in revenue, both missing market expectations.
  • Subsidiary Safariland secured a $61 million, five-year contract with the FBI for ballistic panels and armor systems.

Warren B. Kanders, serving as both Chief Executive Officer and Chairman of Cadre Holdings, Inc. (NASDAQ:CDRE), executed a series of stock sales totaling 75,000 shares across two separate dates in June 2026. According to a Form 4 filing submitted to the Securities and Exchange Commission, these transactions resulted in proceeds of approximately $2.07 million. The divestment was facilitated indirectly through Kanders SAF, LLC, an entity for which Mr. Kanders acts as the sole manager and member.

The timing of these sales coincides with a period of significant downward pressure on CDRE shares. The stock was trading near its 52-week low of $25.73 at the time of the report, marking a substantial 34% decline over the preceding six months. Despite this recent market performance, InvestingPro analysis indicates that the stock may be trading below its fair value, noting that the company continues to maintain profitability. Comprehensive analysis of CDRE's valuation is available through a dedicated Pro Research Report, which is part of a broader suite of over 1,400 reports covering US equities.

On June 18, 2026, Kanders SAF, LLC initiated the sale of 25,000 shares. This initial tranche was executed across multiple transactions at prices ranging from $27.49 to $28.42 per share, resulting in a weighted average price of $27.86 per share. Four days later, on June 22, the entity disposed of an additional 50,000 shares. These subsequent transactions occurred within a narrower price band of $27.28 to $27.67 per share, yielding a weighted average price of $27.43 per share.

Following these dispositions, Kanders SAF, LLC retains a substantial position in the company, holding 9,617,039 shares of Cadre Holdings common stock. Mr. Kanders maintains direct ownership of 22,888 shares. Furthermore, he holds indirect interests through two separate Roth IRAs: the Warren B. Kanders Roth IRA, which contains 1,305,650 shares, and the Allison Kanders Roth IRA, which holds 23,450 shares. Allison Kanders is identified as Mr. Kanders' spouse. In the filing, Mr. Kanders explicitly disclaims beneficial ownership of the securities held within the Allison Kanders Roth IRA, except for the extent of his pecuniary interest in the account.

Key Market and Sector Developments

  • Executive Divestment Activity: The sale of 75,000 shares by the CEO and Chairman highlights ongoing insider transaction monitoring, a key metric for assessing executive confidence and capital allocation within the real estate and defense sectors.
  • Real Estate Market Valuation: CDRE's stock performance, down 34% over six months and near its 52-week low, reflects broader valuation pressures in the commercial real estate sector, though underlying profitability remains intact.
  • Defense and Safety Equipment Contracts: The subsidiary Safariland's acquisition of a $61 million contract underscores continued demand in the government safety and ballistic protection market, impacting the defense and law enforcement equipment supply chain.

Financial Performance and Strategic Partnerships

In other recent corporate developments, Cadre Holdings reported its first-quarter 2026 earnings results, which failed to meet consensus market expectations. The company reported an earnings per share of $0.05, which was half of the anticipated $0.10. Revenue also slightly missed the forecast, coming in at $155.4 million compared to the expected $156.66 million.

Despite the earnings miss, strategic growth continues within its subsidiary operations. Safariland secured a significant five-year contract valued at $61 million with the Federal Bureau of Investigation. This agreement involves the supply of ballistic panels for Predictive Ballistics LLC's Overt Armor Kit. The contract also extends the availability of this armor system to the United States Marshals Service, the Drug Enforcement Administration, and other Department of Justice agencies. These developments highlight Cadre Holdings' recent activities in both financial performance and strategic partnerships.

Risks and Uncertainties

  • Earnings Shortfall Risk: The Q1 earnings miss, with EPS falling to half of expectations and revenue slightly below forecasts, indicates potential challenges in maintaining consistent profitability and meeting market guidance.
  • Stock Price Volatility: The 34% decline over the past six months and trading near the 52-week low suggest significant market volatility and potential downside risk for investors, despite claims of undervaluation.
  • Dependence on Government Contracts: The reliance on a single major government contract for Safariland introduces concentration risk, where performance and revenue are heavily tied to federal agency procurement cycles and budget allocations.

For investors evaluating CDRE, the fastest way to determine current valuation is through a Fair Value calculator that utilizes a mix of 17 proven industry valuation models for maximum accuracy. Accessing the bottom line for CDRE plus thousands of other stocks can help identify potential opportunities within the broader market.

Risks

  • Q1 earnings and revenue missed market forecasts, indicating potential profitability or guidance challenges.
  • Stock declined 34% over six months and trades near its 52-week low, reflecting significant market volatility.
  • Heavy reliance on government contracts introduces procurement and budget-related uncertainty.

More from Insider Trading

Guardant Health Director Tariq Musa Divests $255,893 in Shares Amid Valuation Questions Jun 23, 2026 BETA Technologies CEO Kyle Clark Executes Structured Stock Sales via Trust Jun 23, 2026 BETA Technologies CEO Kyle Clark Executes $712K Stock Sale Under Pre-Arranged Plan Jun 23, 2026 Guardant Health Director Myrtle Potter Sells $204,084 in Stock Jun 23, 2026 Upwork CEO Hayden Brown Offloads $191,280 in Stock Amid Equity Vesting Jun 23, 2026